Novel mechanisms and clinical trial endpoints in intestinal fibrosis*
Year: 2021
Type: review
Abstract: The incidence of inflammatory bowel diseases (IBD) worldwide has resulted in a global public health challenge. Intestinal fibrosis leading to stricture formation and bowel obstruction is a frequent complication in Crohn's disease (CD), and the lack of anti-fibrotic therapies makes elucidation of fibrosis mechanisms a priority. Progress has shown that mesenchymal cells, cytokines, microbial products, and mesenteric adipocytes are jointly implicated in the pathogenesis of intestinal fibrosis. This recent information puts prevention or reversal of intestinal strictures within reach through innovative therapies validated by reliable clinical trial endpoints. Here, we review the role of immune and non-immune components of the pathogenesis of intestinal fibrosis, including new cell clusters, cytokine networks, host-microbiome interactions, creeping fat, and their translation for endpoint development in anti-fibrotic clinical trials.
Source: Immunological Reviews
DOI: 10.1111/imr.12974
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funders: Crohn's and Colitis Foundation of America, Leona M. and Harry B. Helmsley Charitable Trust, Cleveland Clinic Foundation, Kenneth Rainin Foundation, American Association of Heart Failure Nurses, National Institute on Alcohol Abuse and Alcoholism, National Heart, Lung, and Blood Institute, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Functional Genomics of Atrial Fibrillation, Creeping fat and Crohn's disease associated strictures, G2696576206, G2765431181, Microbiota in Intestinal Fibrosis, G4722588348, G4803435082, Gut Microbiota and Cardiometabolic Diseases, G5892793931, The Role of Bacterial Choline Metabolism in Host Stress Responses, G760221107, Microbial metabolites and Innate Immunity in AH: Biomarkers of injury and repair, Alcohol and tissue injury, from mechanisms to treatments, The Cleveland Digestive Diseases Research Core Center (DDRCC), Combined Training Program in Digestive Disease Sciences
OpenAlex ID: W3161850476
